Jennifer K. Gajan, Ph.D.
Affiliations: | 2013 | Pharmaceutical Sciences and Pharmacogenomics | University of California, San Francisco, San Francisco, CA |
Area:
Pharmacy, Cell BiologyGoogle:
"Jennifer Gajan"Parents
Sign in to add mentorNeil P. Shah | grad student | 2013 | UCSF | |
(Mechanisms of Action of Kinase Inhibitors in Chronic Myeloid Leukemia.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gajan J, Lasater E, Tajon C, et al. (2013) Abstract 4308: A model of oncogene addiction: BCR-ABL hijacks signaling through a MEK-dependent process and inhibits growth factor-mediated signal transduction. Cancer Research. 73: 4308-4308 |
Gajan J, Oses-prieto J, Lasater EA, et al. (2011) Abstract 2923: Phosphoproteomic assessment of CML cells following transient potent inhibition with dasatinib is associated with durable alteration of the STAT5 and RAF/MEK/ERK pathways Cancer Research. 71: 2923-2923 |
Gajan J, Kasap C, Shah N. (2010) Abstract 1659: The mechanism of action of clinically effective dual Abl/Aurora kinase inhibitors does not involve BCR-ABL inhibition Cancer Research. 70: 1659-1659 |